<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35630712</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1420-3049</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>10</Issue><PubDate><Year>2022</Year><Month>May</Month><Day>18</Day></PubDate></JournalIssue><Title>Molecules (Basel, Switzerland)</Title><ISOAbbreviation>Molecules</ISOAbbreviation></Journal><ArticleTitle>Hit-to-Lead Short Peptides against Dengue Type 2 Envelope Protein: Computational and Experimental Investigations.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3233</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/molecules27103233</ELocationID><Abstract><AbstractText>Data from the World Health Organisation show that the global incidence of dengue infection has risen drastically, with an estimated 400 million cases of dengue infection occurring annually. Despite this worrying trend, there is still no therapeutic treatment available. Herein, we investigated short peptide fragments with a varying total number of amino acid residues (peptide fragments) from previously reported dengue virus type 2 (DENV2) peptide-based inhibitors, DN58wt (GDSYIIIGVEPGQLKENWFKKGSSIGQMF), DN58opt (TWWCFYFCRRHHPFWFFYRHN), DS36wt (LITVNPIVTEKDSPVNIEAE), and DS36opt (RHWEQFYFRRRERKFWLFFW), aided by in silico approaches: peptide-protein molecular docking and 100 ns of molecular dynamics (MD) simulation via molecular mechanics using Poisson-Boltzmann surface area (MMPBSA) and molecular mechanics generalised Born surface area (MMGBSA) methods. A library of 11,699 peptide fragments was generated, subjected to in silico calculation, and the candidates with the excellent binding affinity and shown to be stable in the DI-DIII binding pocket of DENV2 envelope (E) protein were determined. Selected peptides were synthesised using conventional Fmoc solid-phase peptide chemistry, purified by RP-HPLC, and characterised using LCMS. In vitro studies followed, to test for the peptides' toxicity and efficacy in inhibiting the DENV2 growth cycle. Our studies identified the electrostatic interaction (from free energy calculation) to be the driving stabilising force for the E protein-peptide interactions. Five key E protein residues were also identified that had the most interactions with the peptides: (polar) LYS36, ASN37, and ARG350, and (nonpolar) LEU351 and VAL354; these residues might play crucial roles in the effective binding interactions. One of the peptide fragments, DN58opt_8-13 (PFWFFYRH), showed the best inhibitory activity, at about 63% DENV2 plague reduction, compared with no treatment. This correlates well with the in silico studies in which the peptide possessed the lowest binding energy (-9.0 kcal/mol) and was maintained steadily within the binding pocket of DENV2 E protein during the MD simulations. This study demonstrates the use of computational studies to expand research on lead optimisation of antiviral peptides, thus explaining the inhibitory potential of the designed peptides.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zaidi</LastName><ForeName>Norburhanuddin Johari</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>Peptide Laboratory, Department of Chemistry, Faculty of Science, Universiti Malaya, Kuala Lumpur 50603, Malaysia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Drug Design &amp; Development Research Group, Department of Chemistry, Faculty of Science, Universiti Malaya, Kuala Lumpur 50603, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdullah</LastName><ForeName>Adib Afandi</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Drug Design &amp; Development Research Group, Department of Chemistry, Faculty of Science, Universiti Malaya, Kuala Lumpur 50603, Malaysia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Natural Products Research and Drug Discovery (CENAR), Universiti Malaya, Kuala Lumpur 50603, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heh</LastName><ForeName>Choon Han</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Drug Design &amp; Development Research Group, Department of Chemistry, Faculty of Science, Universiti Malaya, Kuala Lumpur 50603, Malaysia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur 50603, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chun-Hung</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Institute of Biological Chemistry, Academia Sinica, Nankang, Taipei 115, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Othman</LastName><ForeName>Rozana</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-8260-9252</Identifier><AffiliationInfo><Affiliation>Drug Design &amp; Development Research Group, Department of Chemistry, Faculty of Science, Universiti Malaya, Kuala Lumpur 50603, Malaysia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Natural Products Research and Drug Discovery (CENAR), Universiti Malaya, Kuala Lumpur 50603, Malaysia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur 50603, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmad Fuaad</LastName><ForeName>Abdullah Al Hadi</ForeName><Initials>AAH</Initials><Identifier Source="ORCID">0000-0002-0880-0112</Identifier><AffiliationInfo><Affiliation>Peptide Laboratory, Department of Chemistry, Faculty of Science, Universiti Malaya, Kuala Lumpur 50603, Malaysia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Drug Design &amp; Development Research Group, Department of Chemistry, Faculty of Science, Universiti Malaya, Kuala Lumpur 50603, Malaysia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>IF070-2020</GrantID><Agency>Ministry of Higher Education</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Molecules</MedlineTA><NlmUniqueID>100964009</NlmUniqueID><ISSNLinking>1420-3049</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="Y">Dengue</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="Y">Dengue Virus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062105" MajorTopicYN="N">Molecular Docking Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">dengue</Keyword><Keyword MajorTopicYN="N">envelope protein</Keyword><Keyword MajorTopicYN="N">molecular docking</Keyword><Keyword MajorTopicYN="N">molecular dynamics</Keyword><Keyword MajorTopicYN="N">peptide</Keyword><Keyword MajorTopicYN="N">plaque assay</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>5</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>28</Day><Hour>1</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35630712</ArticleId><ArticleId IdType="pmc">PMC9146555</ArticleId><ArticleId IdType="doi">10.3390/molecules27103233</ArticleId><ArticleId IdType="pii">molecules27103233</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization  Dengue and Severe Dengue.  [(accessed on 1 April 2022)].  Available online:  https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue.</Citation></Reference><Reference><Citation>Ebi K.L., Nealon J. Dengue in a changing climate. Environ. Res. 2016;151:115&#x2013;123. doi: 10.1016/j.envres.2016.07.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envres.2016.07.026</ArticleId><ArticleId IdType="pubmed">27475051</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh A., Robinson A.W.T. Vector Control Interventions to Prevent Dengue: Current Situation and Strategies for Future Improvements to Management of Aedes in India. J. Emerg. Infect. Dis. 2017;2:1000123. doi: 10.4172/2472-4998.1000123.</Citation><ArticleIdList><ArticleId IdType="doi">10.4172/2472-4998.1000123</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu X., Bambrick H., Pongsumpun P., Dhewantara P.W., Toan D.T.T., Hu W. Dengue outbreaks in the COVID-19 era: Alarm raised for Asia. PLoS Negl. Trop. Dis. 2021;15:e0009778. doi: 10.1371/journal.pntd.0009778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0009778</ArticleId><ArticleId IdType="pmc">PMC8500420</ArticleId><ArticleId IdType="pubmed">34624031</ArticleId></ArticleIdList></Reference><Reference><Citation>Mustafa M.S., Rasotgi V., Jain S., Gupta V. Discovery of fifth serotype of dengue virus (DENV-5): A new public health dilemma in dengue control. Med. J. Armed Forces India. 2015;71:67&#x2013;70. doi: 10.1016/j.mjafi.2014.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mjafi.2014.09.011</ArticleId><ArticleId IdType="pmc">PMC4297835</ArticleId><ArticleId IdType="pubmed">25609867</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorigatti I., Donnelly C.A., Laydon D.J., Small R., Jackson N., Coudeville L., Ferguson N.M. Refined efficacy estimates of the Sanofi Pasteur dengue vaccine CYD-TDV using machine learning. Nat. Commun. 2018;9:3644. doi: 10.1038/s41467-018-06006-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-06006-6</ArticleId><ArticleId IdType="pmc">PMC6128884</ArticleId><ArticleId IdType="pubmed">30194294</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitehead S.S., Durbin A.P., Pierce K.K., Elwood D., McElvany B.D., Fraser E.A., Carmolli M.P., Tibery C.M., Hynes N.A., Jo M., et al. In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination. PLoS Negl. Trop. Dis. 2017;11:e0005584. doi: 10.1371/journal.pntd.0005584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0005584</ArticleId><ArticleId IdType="pmc">PMC5436874</ArticleId><ArticleId IdType="pubmed">28481883</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas S.J., Yoon I.K. A review of Dengvaxia(R): Development to deployment. Hum. Vaccin. Immunother. 2019;15:2295&#x2013;2314. doi: 10.1080/21645515.2019.1658503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2019.1658503</ArticleId><ArticleId IdType="pmc">PMC6816420</ArticleId><ArticleId IdType="pubmed">31589551</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellan K., Thayan R., Raman J., Hidari K., Ismail N., Sabaratnam V. Anti-viral activity of culinary and medicinal mushroom extracts against dengue virus serotype 2: An in-vitro study. BMC Complement. Altern. Med. 2019;19:260. doi: 10.1186/s12906-019-2629-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12906-019-2629-y</ArticleId><ArticleId IdType="pmc">PMC6751638</ArticleId><ArticleId IdType="pubmed">31533688</ArticleId></ArticleIdList></Reference><Reference><Citation>Pujar G.V., Sethu A.K., Bhagyalalitha M., Singh M. Dengue structural proteins as antiviral drug targets: Current status in the drug discovery &amp; development. Eur. J. Med. Chem. 2021;221:113527. doi: 10.1016/j.ejmech.2021.113527.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2021.113527</ArticleId><ArticleId IdType="pubmed">34020338</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao M., Kielian M. Domain III from class II fusion proteins functions as a dominant-negative inhibitor of virus membrane fusion. J. Cell Biol. 2005;171:111&#x2013;120. doi: 10.1083/jcb.200507075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200507075</ArticleId><ArticleId IdType="pmc">PMC2171229</ArticleId><ArticleId IdType="pubmed">16216925</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y., Rahman N.A., Othman R., Hu P., Huang M. Computational identification of self-inhibitory peptides from envelope proteins. Proteins. 2012;80:2154&#x2013;2168. doi: 10.1002/prot.24105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prot.24105</ArticleId><ArticleId IdType="pubmed">22544824</ArticleId></ArticleIdList></Reference><Reference><Citation>Baharuddin A., Amir Hassan A., Othman R., Xu Y., Huang M., Ario Tejo B., Yusof R., Abdul Rahman N., Othman S. Dengue envelope domain III-peptide binding analysis via tryptophan fluorescence quenching assay. Chem. Pharm. Bull. 2014;62:947&#x2013;955. doi: 10.1248/cpb.c14-00165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1248/cpb.c14-00165</ArticleId><ArticleId IdType="pubmed">25273053</ArticleId></ArticleIdList></Reference><Reference><Citation>Trott O., Olson A.J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 2009;31:455&#x2013;461. doi: 10.1002/jcc.21334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcc.21334</ArticleId><ArticleId IdType="pmc">PMC3041641</ArticleId><ArticleId IdType="pubmed">19499576</ArticleId></ArticleIdList></Reference><Reference><Citation>BIOVIA Discovery Studio. Dassault Syst&#xe8;mes; San Diego, CA, USA:  [(accessed on 6 October 2021)].  Version 4.0. Available online:  https://www.accelrys.com.</Citation></Reference><Reference><Citation>Westbrook J., Feng Z., Chen L., Yang H., Berman H.M. The Protein Data Bank and structural genomics. Nucleic Acids Res. 2003;31:489&#x2013;491. doi: 10.1093/nar/gkg068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkg068</ArticleId><ArticleId IdType="pmc">PMC165515</ArticleId><ArticleId IdType="pubmed">12520059</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung J.J., Hsieh M.T., Young M.J., Kao C.L., King C.C., Chang W. An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells. J. Virol. 2004;78:378&#x2013;388. doi: 10.1128/JVI.78.1.378-388.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.1.378-388.2004</ArticleId><ArticleId IdType="pmc">PMC303388</ArticleId><ArticleId IdType="pubmed">14671119</ArticleId></ArticleIdList></Reference><Reference><Citation>Law R.J., Capener C., Baaden M., Bond P.J., Campbell J., Patargias G., Arinaminpathy Y., Sansom M.S. Membrane protein structure quality in molecular dynamics simulation. J. Mol. Graph. Model. 2005;24:157&#x2013;165. doi: 10.1016/j.jmgm.2005.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmgm.2005.05.006</ArticleId><ArticleId IdType="pubmed">16102990</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y., Tai W., Wang N., Li X., Jiang S., Debnath A.K., Du L., Chen S. Identification of Novel Natural Products as Effective and Broad-Spectrum Anti-Zika Virus Inhibitors. Viruses. 2019;11:1091. doi: 10.3390/v11111019.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11111019</ArticleId><ArticleId IdType="pmc">PMC6893700</ArticleId><ArticleId IdType="pubmed">31684080</ArticleId></ArticleIdList></Reference><Reference><Citation>Arumugam A.C., Agharbaoui F.E., Khazali A.S., Yusof R., Abd Rahman N., Ahmad Fuaad A.A.H. Computational-aided design: Minimal peptide sequence to block dengue virus transmission into cells. J. Biomol. Struct. Dyn. 2020;31:1&#x2013;10. doi: 10.1080/07391102.2020.1866074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07391102.2020.1866074</ArticleId><ArticleId IdType="pubmed">33382015</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Guardia C., Quijada M., Lleonart R. Phage-Displayed Peptides Selected to Bind Envelope Glycoprotein Show Antiviral Activity against Dengue Virus Serotype 2. Adv. Virol. 2017;2017:1827341. doi: 10.1155/2017/1827341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/1827341</ArticleId><ArticleId IdType="pmc">PMC5610824</ArticleId><ArticleId IdType="pubmed">29081802</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothan H.A., Bahrani H., Mohamed Z., Teoh T.C., Shankar E.M., Rahman N.A., Yusof R. A combination of doxycycline and ribavirin alleviated chikungunya infection. PLoS ONE. 2015;10:e0126360. doi: 10.1371/journal.pone.0126360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0126360</ArticleId><ArticleId IdType="pmc">PMC4430285</ArticleId><ArticleId IdType="pubmed">25970853</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhoot M.A., Rathinam A.K., Wang S.M., Manikam R., Sekaran S.D. Inhibition of dengue virus entry into target cells using synthetic antiviral peptides. Int. J. Med. Sci. 2013;10:719&#x2013;729. doi: 10.7150/ijms.5037.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijms.5037</ArticleId><ArticleId IdType="pmc">PMC3638295</ArticleId><ArticleId IdType="pubmed">23630436</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettersen E.F., Goddard T.D., Huang C.C., Couch G.S., Greenblatt D.M., Meng E.C., Ferrin T.E. UCSF Chimera--a visualization system for exploratory research and analysis. J. Comput. Chem. 2004;25:1605&#x2013;1612. doi: 10.1002/jcc.20084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcc.20084</ArticleId><ArticleId IdType="pubmed">15264254</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z., Lasker K., Schneidman-Duhovny D., Webb B., Huang C.C., Pettersen E.F., Goddard T.D., Meng E.C., Sali A., Ferrin T.E. UCSF Chimera, MODELLER, and IMP: An integrated modeling system. J. Struct. Biol. 2012;179:269&#x2013;278. doi: 10.1016/j.jsb.2011.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2011.09.006</ArticleId><ArticleId IdType="pmc">PMC3410985</ArticleId><ArticleId IdType="pubmed">21963794</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapovalov M.V., Dunbrack R.L., Jr. A smoothed backbone-dependent rotamer library for proteins derived from adaptive kernel density estimates and regressions. Structure. 2011;19:844&#x2013;858. doi: 10.1016/j.str.2011.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2011.03.019</ArticleId><ArticleId IdType="pmc">PMC3118414</ArticleId><ArticleId IdType="pubmed">21645855</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier J.A., Martinez C., Kasavajhala K., Wickstrom L., Hauser K.E., Simmerling C. ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB. J. Chem. Theory Comput. 2015;11:3696&#x2013;3713. doi: 10.1021/acs.jctc.5b00255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jctc.5b00255</ArticleId><ArticleId IdType="pmc">PMC4821407</ArticleId><ArticleId IdType="pubmed">26574453</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen R.A., Liu L., Ghaderi N., Johns A., Hatcher M.E., Mueller L.J. The Amide Rotational Barriers in Picolinamide and Nicotinamide: NMR and ab Initio Studies. J. Am. Chem. Soc. 2003;125:10125&#x2013;10132. doi: 10.1021/ja028751j.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ja028751j</ArticleId><ArticleId IdType="pubmed">12914477</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim S.K., Othman R., Yusof R., Heh C.H. Rational Drug Discovery of HCV Helicase Inhibitor: Improved Docking Accuracy with Multiple Seeding in AutoDock Vina and In Situ Minimization. Curr. Comput. Aided Drug Des. 2017;13:160&#x2013;169. doi: 10.2174/1573409912666161130122622.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1573409912666161130122622</ArticleId><ArticleId IdType="pubmed">27903217</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen W.J., Balius T.E., Mukherjee S., Brozell S.R., Moustakas D.T., Lang P.T., Case D.A., Kuntz I.D., Rizzo R.C. DOCK 6: Impact of new features and current docking performance. J. Comput. Chem. 2015;36:1132&#x2013;1156. doi: 10.1002/jcc.23905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcc.23905</ArticleId><ArticleId IdType="pmc">PMC4469538</ArticleId><ArticleId IdType="pubmed">25914306</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindorff-Larsen K., Piana S., Palmo K., Maragakis P., Klepeis J.L., Dror R.O., Shaw D.E. Improved side-chain torsion potentials for the Amber ff99SB protein force field. Proteins. 2010;78:1950&#x2013;1958. doi: 10.1002/prot.22711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prot.22711</ArticleId><ArticleId IdType="pmc">PMC2970904</ArticleId><ArticleId IdType="pubmed">20408171</ArticleId></ArticleIdList></Reference><Reference><Citation>Darden T., York D., Pedersen L. Particle mesh Ewald: AnN&#x22c5;log(N) method for Ewald sums in large systems. J. Chem. Phys. 1993;98:10089&#x2013;10092. doi: 10.1063/1.464397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1063/1.464397</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieb E.H., Thirring W.E. Universal nature of van der Waals forces for Coulomb systems. Phys. Rev. A. 1986;34:40&#x2013;46. doi: 10.1103/PhysRevA.34.40.</Citation><ArticleIdList><ArticleId IdType="doi">10.1103/PhysRevA.34.40</ArticleId><ArticleId IdType="pubmed">9897223</ArticleId></ArticleIdList></Reference><Reference><Citation>Casalino L., Gaieb Z., Goldsmith J.A., Hjorth C.K., Dommer A.C., Harbison A.M., Fogarty C.A., Barros E.P., Taylor B.C., McLellan J.S., et al. Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein. ACS Cent. Sci. 2020;6:1722&#x2013;1734. doi: 10.1021/acscentsci.0c01056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acscentsci.0c01056</ArticleId><ArticleId IdType="pmc">PMC7523240</ArticleId><ArticleId IdType="pubmed">33140034</ArticleId></ArticleIdList></Reference><Reference><Citation>Salomon-Ferrer R., Gotz A.W., Poole D., Le Grand S., Walker R.C. Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 2. Explicit Solvent Particle Mesh Ewald. J. Chem. Theory Comput. 2013;9:3878&#x2013;3888. doi: 10.1021/ct400314y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ct400314y</ArticleId><ArticleId IdType="pubmed">26592383</ArticleId></ArticleIdList></Reference><Reference><Citation>Salomon-Ferrer R., Case D.A., Walker R.C. An overview of the Amber biomolecular simulation package. Wiley Interdiscip. Rev. Comput. 2013;3:198&#x2013;210. doi: 10.1002/wcms.1121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wcms.1121</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuaad A.A., Skwarczynski M., Toth I. The Use of Microwave-Assisted Solid-Phase Peptide Synthesis and Click Chemistry for the Synthesis of Vaccine Candidates Against Hookworm Infection. Methods Mol. Biol. 2016;1403:639&#x2013;653. doi: 10.1007/978-1-4939-3387-7_36.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-3387-7_36</ArticleId><ArticleId IdType="pubmed">27076158</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>